Handelsbanken Fonder Ab Optimize Rx Corp Transaction History

Handelsbanken Fonder Ab

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$13.77 - $22.04 $3.93 Million - $6.29 Million	-285,600 Reduced 55.34%	230,500 $3.87 Million
Q2 2022 Aug 03, 2022	SELL	$21.94 - $40.49 $634,066 - $1.17 Million	-28,900 Reduced 5.3%	516,100 $14.1 Million
Q1 2022 May 11, 2022	SELL	$35.27 - $62.91 $529,050 - $943,650	-15,000 Reduced 2.68%	545,000 $20.6 Million
Q4 2021 Feb 08, 2022	BUY	$53.57 - $98.0 $2.65 Million - $4.85 Million	49,500 Added 9.7%	560,000 $34.8 Million
Q3 2021 Nov 10, 2021	SELL	$50.93 - $85.55 $5.09 Million - $8.56 Million	-100,000 Reduced 16.38%	510,500 $43.7 Million

Q2 2021 Aug 03, 2021	BUY	$42.76 - $63.33 $1.28 Million - $1.9 Million	30,000 Added 5.17%	610,500 $37.8 Million
Q1 2021 Apr 29, 2021	SELL	$33.36 - $62.2 $984,120 - $1.83 Million	-29,500 Reduced 4.84%	580,500 $28.3 Million
Q4 2020 Feb 11, 2021	BUY	$19.04 - $33.1 $4.19 Million - $7.28 Million	220,000 Added 56.41%	610,000 $19 Million
Q3 2020 Nov 13, 2020	BUY	$12.99 - $21.78 $5.07 Million - $8.49 Million	390,000 New	390,000 $8.13 Million

101

12.9M

18.6K

1.1K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $180M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.